Neograft Technologies, Inc.
Funding rounds
5 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Jan 2017 | $5 M | No. 5 | $2 to $10 million | equity | SEC | |
| Jul 2014 | $11 M | No. 4 | $10 to $50 million | equity | SEC | |
| Aug 2013 | $4 M | No. 3 | $2 to $10 million | equity | SEC | |
| Dec 2010 | $8 M | No. 2 | $2 to $10 million | equity | SEC | |
| Jan 2010 | $6 M | No. 1 | $2 to $10 million | equity | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Neograft Technologies, Inc. chose not to state its revenue in its newest notice of a funding round (Jan 2017).
SEC Form D · Jan 2017
The industry group it chose in its notices: Other Health Care.
SEC Form D · Jan 2017
That is all the official record says: Neograft Technologies, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of Neograft Technologies, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 5 rounds above had up to 7 investors.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Jon McGrath | Executive officer | Jan 2017 |
| F. Dietz David | Executive officer | Aug 2011 |
| McGrath Jon | Executive officer | Aug 2011 |
| David Wagner | Executive officer | Dec 2010 |
| David S Smith | Executive officer | Jan 2010 |
| David W Wagner | Executive officer | Jan 2010 |
| Jon W McGrath | Executive officer | Jan 2010 |
| Richard W Buckingham | Executive officer | Jan 2010 |
| Brad Richard Petersen | Director | Jan 2017 |
| Christopher C. Petersen | Director | Jan 2017 |
| Jon McGrath | Director | Jan 2017 |
| Michael Richard Tovian | Director | Jan 2017 |
| Richard C. Petersen, Jr. | Director | Jan 2017 |
| Thomas Richard Dugan | Director | Jan 2017 |
| Dugan Thomas | Director | Jul 2014 |
| John Petersen | Director | Jul 2014 |
| Paul Southworth | Director | Jul 2014 |
| Richard Petersen | Director | Jul 2014 |
| Thomas Dugan | Director | Aug 2013 |
| John M. Petersen | Director | Aug 2011 |
| McGrath Jon | Director | Aug 2011 |
| Paul C. Southworth | Director | Aug 2011 |
| Thomas C. Dugan | Director | Aug 2011 |
| David Wagner | Director | Dec 2010 |
| Richard Buckingham | Director | Dec 2010 |
| David W Wagner | Director | Jan 2010 |
| Richard W Buckingham | Director | Jan 2010 |
| Richard W Petersen | Director | Jan 2010 |